Adherence to placebo and mortality in the Beta Blocker Evaluation of Survival Trial (BEST) (Q35854669)

10 August 2017

Adherence to placebo and mortality in the Beta Blocker Evaluation of Survival Trial (BEST) (English)

1 reference

10 August 2017

0 references

Alice Pressman

1

1 reference

10 August 2017

Andrew L Avins

2

1 reference

10 August 2017

John Neuhaus

3

1 reference

10 August 2017

Lynn Ackerson

4

1 reference

10 August 2017

Peter Rudd

5

1 reference

10 August 2017

language of work or name

English

0 references

publication date

12 January 2012

1 reference

Contemporary Clinical Trials

10 August 2017

1 reference

10 August 2017

33

1 reference

10 August 2017

3

1 reference

10 August 2017

492-498

1 reference

Placebo adherence and its association with morbidity and mortality in the studies of left ventricular dysfunction

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312975

Adherence to both cotrimoxazole and placebo is associated with improved survival among HIV-infected Zambian children.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312975

A meta-analysis of the association between adherence to drug therapy and mortality

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312975

Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312975

The relationship of treatment adherence to the risk of death after myocardial infarction in women

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312975

Adherence to treatment and health outcomes

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312975

Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312975

Treatment adherence and risk of death after a myocardial infarction

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312975

Poor adherence to placebo or amiodarone therapy predicts mortality: results from the CAMIAT study. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3312975

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

24 September 2018

1 reference

12 December 2020

The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering

1 reference

12 December 2020

Adherence and arrhythmic mortality in the Cardiac Arrhythmia Suppression Trial (CAST)

1 reference

12 December 2020

Design of the Beta-Blocker Evaluation Survival Trial (BEST). The BEST Steering Committee

1 reference

12 December 2020

10.1016/J.CCT.2011.12.003

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

22265975

1 reference